Daewon Pharmaceutical said its oral semaglutide candidate DW5324 showed up to 3.14 times higher drug exposure than Novo’s ...

People aged 70 or older account for about 70 percent of reported Carbapenem-Resistant Enterobacterales (CRE) cases in Korea, ...

A petition opposing the introduction of medication abortion has been referred to the National Assembly’s Health and Welfare ...

LigaChem Biosciences said Monday its claudin 18.2 (CLDN18.2)-targeting antibody-drug conjugate (ADC) LCB02A suppressed tumor growth for about two months after a single dose in animal models of gastric ...

MADRID, Spain -- By Kim Yun-mi / Korea Biomedical Review correspondent -- “I think this drug will be a game ...

Genome & Company said Monday it has acquired a 64.46 percent stake in Allbloom, a K-beauty exporter and distributor serving the U.S. market, through its newly established wholly owned subsidiary, Bloo ...

MADRID, Spain -- By Hong Sook / Korea Biomedical Review correspondent -- The Korea Drug Development Fund (KDDF) plans to ...

Vetter, a leading global contract development and manufacturing organization (CDMO), said it has received a Red Dot Award in ...

Samyang Biopharm and CrossPoint Therapeutics signed a memorandum of understanding last Friday to develop next-generation gene ...

News of a new cancer treatment recently made headlines on major online portals.The treatment, which drew attention from ...

“Echocardiography is more than pressing a button to take pictures. It means reading blood flow and pressure in a constantly ...

MADRID, Spain -- By Hong Sook / Korea Biomedical Review correspondent -- ABL Bio is advancing dose optimization for ...